Cerus: Pay

Cerus paid its 5 named executives $10.9M in total in FY2025 (Dec). CEO William M. Greenman was paid $3.8M of that.

Pay$100 in the stock at the end of FY20 → $42
CEO pay is from each proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Pay of each named executive

William M. GreenmanPresident and Chief Executive Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Vivek JayaramanChief Operating Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years
Kevin D. GreenChief Financial Officer
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Chrystal JensenChief Legal Officer, General Counsel and Secretary
FY2025 (Dec)
FY2024 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
4 years
Richard BenjaminChief Medical Officer
FY2025 (Dec)
FY2023 (Dec)
FY2022 (Dec)Not disclosed
FY2021 (Dec)Not disclosed
4 years

CEO pay against the pay peers

No CEO pay of the disclosed peers is on file for FY2025 (Dec).

  1. 1Cerus
  2. 2Akebia Therapeutics [Nasdaq: AKBA]Not disclosed
  3. 3AngioDynamics, Inc. [Nasdaq: ANGO]Not disclosed
  4. 4Anika Therapeutics [Nasdaq: ANIK]Not disclosed
  5. 5Ardelyx, Inc. [Nasdaq: ARDX]Not disclosed
  6. 6BioLife Solutions, Inc. [Nasdaq: BLFS]Not disclosed
  7. 7CareDX, Inc. [Nasdaq: CDNA]Not disclosed
  8. 8Codexis, Inc. [Nasdaq: CDXS]Not disclosed
  9. 9Collegium Pharmaceutical, Inc. [Nasdaq: COLL]Not disclosed
  10. 10Dynavax Technologies Corp [Nasdaq: DVAX]Not disclosed
  11. 11Heron Therapeutics, Inc. [Nasdaq: HRTX]Not disclosed
  12. 12Innoviva, Inc. [Nasdaq: INVA]Not disclosed
  13. 13Karyopharm Therapeutics Inc. [Nasdaq: KPTI]Not disclosed
  14. 14MacroGenics, Inc. [Nasdaq: MGNX]Not disclosed
  15. 15MannKind Corporation [Nasdaq: MNKD]Not disclosed
  16. 16Mirum Pharmaceuticals, Inc. [Nasdaq: MIRM]Not disclosed
  17. 17OmniAb, Inc. [Nasdaq: OABI]Not disclosed
  18. 18OraSure Technologies, Inc. [Nasdaq: OSUR]Not disclosed
  19. 19Rigel Pharmaceuticals, Inc. [Nasdaq: RIGL]Not disclosed
  20. 20Travere Therapeutics, Inc. [Nasdaq: TVTX]Not disclosed
  21. 21Vanda Pharmaceuticals, Inc. [Nasdaq: VNDA]Not disclosed

Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.